Catalyst Wire Dossier Catalyst Wire Dossier

Sirukumab

sirukumab · Janssen Research & Development, LLC
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Sirukumab, covering 2016-03-09 to 2022-06-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19 [Phase 2]

See pricing